wnt / ß-catenin signaling inhibitor, pharmaceutical composition and method of treating and / or preventing a pathology defined by vascular malformation
IFOM FONDAZIONE ISTITUTO FIRC DI ONCOLOGIA MOLECOLARE;UNIVERSITÀ DEGLI STUDI DI MILANO
发明人:
ELISABETTA DEJANA,MARIA GRAZIA LAMPUGNANI
申请号：
BR112016023519
公开号：
BR112016023519A2
申请日:
2015.04.10
申请国别(地区):
BR
年份:
2018
代理人:
摘要：
an inhibitor of wnt / ß-catenin signaling for use in treatment and / 5 or prevention of a pathology characterized by vascular malformation. the inhibitor may be a small molecule, a protein, a peptide or an antisense nucleic acid. the invention also relates to pharmaceutical compositions and method of treatmentan inhibitor of wnt/ß-catenin signaling for use in the treatment and/5 or prevention of a pathology characterized by vascular malformation. the inhibitor may be a small molecule, a protein, a peptide or an antisense nucleic acid. the invention also relates to pharmaceutical compositions and to method of treatment
